Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 13, 2014 · 10-Q · 44 days after period end · 0001062993-14-004769
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$1.01M | -$151.92K | -$4.54M | -$1.58M |
| EPS Diluted | -$0.03 | -$0.01 | -$0.16 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 13, 2014 · 44 d after period end
